Literature DB >> 486549

Studies on histamine H2 receptors coupled to cardiac adenylate cyclase. Effects of guanylnucleotides and structural requirements for agonist activity.

C L Johnson, H Weinstein, J P Green.   

Abstract

In particulate preparations from guinea-pig ventricle, histamine in the concentration range 10(-6)--10(-3) M caused a 3--5fold stimulation of adenylate cyclase activity which was dependent on the presence of GTP. The effects of fourteen analogs of histamine were examined on this cyclase preparation. Five of the compounds studied proved to be partial agonists relative to histamine while nine others had essentially the same intrinsic activity as histamine. The intrinsic activities of the partial agonists were increased by GppNHp to the extent that dimaprit, which was a partial agonist in the presence of GTP, became a full agonist in the presence of GppNHp. The relative potencies of the full agonists as activators of the cyclase were found to correlate with the relative potencies on physiologically defined H2 receptor systems. Activation of the cyclase by histamine, as well as by several of the agonist analogs, including dimaprit and tolazoline, was completely blocked by the H2 antagonist cimetidine, but was not affected by pharmacologically relevant concentrations of the H1 antagonist mepyramine, the beta-blocker alprenolol, or the alpha-blocker phentolamine. The results suggest that all the agonists studied probably interact with a common H2 receptor site on the cardiac muscle cell leading to activation of adenylate cyclase. The accompanying increase in cyclic AMP is presumably responsible for the chronotropic and inotropic effects of histamine and related compounds on cardiac muscle.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 486549     DOI: 10.1016/0304-4165(79)90350-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

1.  Quantification of H2-agonism by clonidine and dimaprit in an adenylate cyclase assay.

Authors:  D G Trist; P Leff
Journal:  Agents Actions       Date:  1985-04

Review 2.  The Roles of Cardiovascular H2-Histamine Receptors Under Normal and Pathophysiological Conditions.

Authors:  Joachim Neumann; Uwe Kirchhefer; Stefan Dhein; Britt Hofmann; Ulrich Gergs
Journal:  Front Pharmacol       Date:  2021-12-20       Impact factor: 5.810

3.  The effects of cimetidine on histamine atrial chronotropic receptor activity.

Authors:  M J Hughes
Journal:  Agents Actions       Date:  1982-10

4.  N-Methyldimaprit (SK&F92054). A chemical control for the histamine H2-receptor agonist dimaprit.

Authors:  R C Blakemore; C R Ganellin; B K Leigh; M E Parsons; C A Price; I R Smith; W Tertiuk
Journal:  Agents Actions       Date:  1986-10

5.  Effects of RMI 12330A, a new inhibitor of adenylate cyclase on myocardial function and subcellular activity.

Authors:  G Grupp; I L Grupp; C L Johnson; M A Matlib; W Rouslin; A Schwartz; E T Wallick; T Wang; P Wisler
Journal:  Br J Pharmacol       Date:  1980-11       Impact factor: 8.739

6.  Histamine receptors of the microvascular endothelium revealed in situ with a histamine-ferritin conjugate: characteristic high-affinity binding sites in venules.

Authors:  C Heltianu; M Simionescu; N Simionescu
Journal:  J Cell Biol       Date:  1982-05       Impact factor: 10.539

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.